| چکیده انگلیسی مقاله |
Background: The aim of this study was to estimate the prevalence of dysphonia in patients with COVID-19.
Methods: English and Persian studies that reported dysphonia in patients with COVID-19were included. Review and case report studies were excluded. We searched Web of Science, PubMed, Google Scholar, and Scopus from 1 January 2020 until 15 July 2021. The prevalence of dysphonia was obtained by combining the results and weighting the sample size in the corresponding study. Heterogeneity was evaluated using the Cochran Chi-square test and I2.
Results: Of the 1830 articles identified, 7 studies finally (n= 1410 patients) were included in the meta-analysis. Pooled prevalence of the dysphonia was 31% (95%CI:13-.48). The prevalence of dysphonia in men and women with COVID-19 was 28.2% (95%CI:14-.46) and 32.8 (95%CI:.22-.45), respectively.
Discussion: Due to the design of the included studies, the certainty of the results is limited. There was notable heterogeneity in the data, which we interpret not to be due publication bias, but rather as a result of the small sample sizes in studies, or because of the heterogeneity of the COVID-19.About one-third of patients with COVID-19 may have dysphonia as the only symptom. Therefore, one should even be careful in approaching those who have only dysphonia.
Other: There was no source of funding for this review. |
| نویسندگان مقاله |
| Alireza Aghaz
Department of Speech Therapy, School of Rehabilitation Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
| Arash Shahriyari
Department of Psychology, Central Tehran Branch, School of Psychology and Educational Sciences, Islamic Azad University, Tehran, Iran.
| Shiva Panahiaboozar
Department of Psychology, Faculty of Education and Psychology, University of Tehran, Tehran, Iran.
| Hossein Jadidi
Department of Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
| Mohadeseh Khoshgoftar
Department of Health Education and Health Promotion, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
| Edris Choupani
Department of Biotechnology, Faculty of Allied Medicine, Iran University of Medical Science, Tehran, Iran.
| Ehsan Hemmati
Candidate in Neuroscience, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
|